Clinical Significance of Daytime Plasma Orexin-A-Like Immunoreactivity Concentrations in Patients with Obstructive Sleep Apnea Hypopnea Syndrome
Clinical Significance of Daytime Plasma Orexin-A-Like Immunoreactivity Concentrations in Patients with Obstructive Sleep Apnea Hypopnea Syndrome
复制标题
阻塞性睡眠呼吸暂停低通气综合征患者日间血浆食欲素 A 样免疫反应性浓度的临床意义
DOI:
10.1159/000079643
复制
发表时间:
2004
期刊:
影响因子:
3.7
通讯作者:
Kazuhiro Takahashi
中科院分区:
文献类型:
--
作者:
S. Sakurai;Tsuguo Nishijima;Susumu Takahashi;K. Yamauchi;Z. Arihara;Kazuhiro Takahashi
Background: Polysomnography (PSG) tests are very complicated and time consuming, despite their clinical benefits in the diagnosis of patients with obstructive sleep apnea hypopnea syndrome (OSAHS). A plasma marker would be desirable to select patients suspected of OSAHS for further PSG studies. We have recently reported that orexin-A concentrations in plasma collected immediately after waking early in the morning were significantly lower in patients with OSAHS than in controls. Objectives: We conducted the present study to assess the clinical usefulness of the measurement of orexin-A concentrations in plasma obtained in the daytime as a diagnostic predictor to screen patients with OSAHS. Methods: Blood samples were collected in the daytime from 19 male patients with suspected sleep-disordered breathing. Plasma orexin-A concentrations were measured by radioimmunoassay before performing PSG. Results: PSG was conducted in all 19 subjects. PSG showed that 14 subjects had OSAHS and 5 subjects did not. Plasma orexin-A concentrations were significantly lower in patients with OSAHS (4.9 ± 0.8 pmol/l, mean ± SE, n = 14) than in control subjects (12.3 ± 1.9 pmol/l, n = 5) (p = 0.0004). Conclusions: These findings suggest that the orexin-A concentration in plasma obtained even in the daytime may be a useful plasma marker for screening OSAHS.
DOI:
10.1073/pnas.95.1.322
发表时间:
1998-01-06
影响因子:
11.1
作者:
De Lecea, L;Kilduff, TS;Sutcliffe, JG
通讯作者:
Sutcliffe, JG